RTM Vital Signs
PrivateLast Round
Grant
Feb 1, 2024
Est. Valuation
$9.5M
Total Funding Raised
$1.95M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
RTM Vital Signs operates in Healthcare & Life Sciences and is based in Philadelphia, Pennsylvania. Its latest recorded funding round was a Grant round in February 2024.
RTM Vital Signs is a medical device company that develops real-time continuous monitors for vital signs, focusing on cardiac and respiratory function.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Medical AI, Sensors
Business Model
B2B
Customer Profile
Hardware + Subscription, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RTM Vital Signs Comparables
Compare RTM Vital Signs with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Linshom Medical, Inc. | 87% | |
| Strados Labs | 81% | |
| GE HealthCare Technologies Inc. | 69% |
For institutional investors. Book with your work email.
RTM Vital Signs Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 1, 2024 | ||||
| Grant | Sep 1, 2023 | ||||
| Seed | Nov 1, 2020 | ||||
| Grant | Apr 1, 2020 |
For institutional investors. Book with your work email.
RTM Vital Signs Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| CAV Angels | Seed |
| Citizens Financial Group, Inc. | Grant |
| National Institute on Drug Abuse | Grant, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 51% MoM.
- Apr 21, 2026
Monthly visitors increased 37% MoM.
For institutional investors. Book with your work email.
RTM Vital Signs Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about RTM Vital Signs's valuation, stock price, and market status.
Is RTM Vital Signs a public or private company?
RTM Vital Signs is a private company.
What is the current stock price of RTM Vital Signs?
RTM Vital Signs is a private company, so its shares have no public market price. Caplight tracks RTM Vital Signs's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is RTM Vital Signs worth (valuation)?
RTM Vital Signs's valuation is estimated at $9.5M based on funding round data.
Can I buy RTM Vital Signs stock?
RTM Vital Signs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was RTM Vital Signs's last funding round?
RTM Vital Signs's most recent funding round was Grant on February 1, 2024.
Who are the main investors in RTM Vital Signs?
Key investors in RTM Vital Signs include NIH RADx, CAV Angels, Citizens Financial Group, Inc., National Institute on Drug Abuse.
Will RTM Vital Signs IPO soon?
No public IPO plans have been announced for RTM Vital Signs.
How can I track RTM Vital Signs secondary market activity?
Caplight tracks bids, offers, and trades in RTM Vital Signs's shares on secondary markets.